Drug Shortage Report for CABLIVI
Report ID | 225859 |
Drug Identification Number | 02496194 |
Brand name | CABLIVI |
Common or Proper name | caplacizumab |
Company Name | SANOFI-AVENTIS CANADA INC |
Market Status | MARKETED |
Active Ingredient(s) | CAPLACIZUMAB |
Strength(s) | 11MG |
Dosage form(s) | POWDER FOR SOLUTION KIT |
Route of administration | SUBCUTANEOUS INTRAVENOUS |
Packaging size | 1 vial/box |
ATC code | B01AX |
ATC description | |
Reason for shortage | Other (Please describe in comments) |
Anticipated start date | |
Actual start date | 2024-05-01 |
Estimated end date | Unknown |
Actual end date | |
Shortage status | Actual shortage |
Updated date | 2024-05-02 |
Company comments | Business reasons |
Health Canada comments | |
Tier 3 Status | No |
Company contact information | email: CAINTERNET@sanofi.com Telephone: 1-800-265-7927 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v3 | 2024-05-02 | English | Compare |
v2 | 2024-04-22 | French | Compare |
v1 | 2024-04-22 | English | Compare |
Showing 1 to 3 of 3